Nicola S. Meagher

792 Elizabeth St
Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries.

Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries.

Journal: ESMO real world data and digital oncology

Published: August 02, 2026

Association Between β-Lactam Exposure and Clearance of Bacteremia and Acute Kidney Injury in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections - a Post Hoc Analysis of the CAMERA2 Trial.

Association Between β-Lactam Exposure and Clearance of Bacteremia and Acute Kidney Injury in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections - a Post Hoc Analysis of the CAMERA2 Trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: January 28, 2026

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

Journal: British journal of cancer

Published: November 24, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Nature communications

Published: September 22, 2025

A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma.

A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma.

Journal: Histopathology

Published: July 15, 2025

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.

Journal: Gynecologic oncology

Published: March 05, 2025

Antenatal screening for TB disease: a systematic review and meta-analysis.

Antenatal screening for TB disease: a systematic review and meta-analysis.

Journal: IJTLD open

Published: February 11, 2025

Cellular origins of mucinous ovarian carcinoma.

Cellular origins of mucinous ovarian carcinoma.

Journal: The Journal of pathology

Published: November 04, 2024

Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants.

Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants.

Journal: European journal of human genetics : EJHG

Published: June 27, 2024

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Journal: The Journal of clinical investigation

Published: January 31, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026